Theriva Biologics Inc.
Biotechnology
Healthcare
TOVX
1.00 M shares
NYSE MKT US
traded
12 Mar 2025
listed
no
open
1.31
52 week high
5.90
high
1.37
52 week low
1.14
low
1.31
growth
-75.64 %
previous Close
1.35
P/E ratio
-0
market cap
4.09 M
div yield
0
usd
Sep 2024
qoq
revenue
0.00 %
net incoming
-7.73 M
7.09 %
eps
-6.81 %
36.64 %
eps surprise
-29.73 %
net profit margin
-772600000.00 %
0.00 %
operating incoming
-7.89 M
7.08 %
net change in cash
-180.00 K
89.21 %
cash on hand
16.41 M
-1.11 %
cost of revenue
0.00 %
top top